Notify me when Kluge Andreas files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Ltd | Ordinary Shares | 6.8% | $393,638,000 | 22,675,000 | Kluge Andreas | 12 Nov 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|